Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Current burden and health care utilization of inflammatory bowel disease in the United States, 2023-2024.

Intestinal research·2026
Same author

Risk Assessment of Cardiovascular Disease-related Mortality in Metabolic Dysfunction-Associated Steatotic Liver Disease.

Clinical and molecular hepatology·2026
Same author

Contemporary epidemiology of metabolic dysfunction-associated steatotic liver disease.

Expert review of gastroenterology & hepatology·2026
Same author

Impact of Fatigue on Patient-Reported Outcomes and Work Productivity in Chronic Hepatitis B and C: Insights From a Multinational Registry Study.

Journal of viral hepatitis·2026
Same author

Burden of Cardiovascular Complications in Steatotic Liver Disease in the United States.

Clinical and molecular hepatology·2026
Same author

Diabetes-Related Mortality of Hispanic Subpopulations in the United States.

Mayo Clinic proceedings·2026
Same journal

Metabolic Dysfunction-Associated Steatohepatitis: From Fibrosis-Based Risk Stratification to Emerging Therapeutic Strategies.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease and Viral Hepatitis.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction Associated Steatohepatitis (MASH) in Oceania, Central America, and the Caribbean.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Latin America.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Africa: From Burden to Action.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Asia: Epidemiology, Clinical Features, and Management.

Clinics in liver disease·2026
See all related articles

Related Experiment Video

Updated: Jun 23, 2026

Laparoscopic S7 Hepatectomy with Positive Fluorescence Staining
07:43

Laparoscopic S7 Hepatectomy with Positive Fluorescence Staining

Published on: May 9, 2025

The asymptomatic outpatient with abnormal liver function tests.

Michael Krier1, Aijaz Ahmed

  • 1Division of Gastroenterology and Hepatology, Stanford University School of Medicine, 750 Welch Road, Suite # 210, Stanford, CA 94304, USA.

Clinics in Liver Disease
|May 16, 2009
PubMed
Summary
This summary is machine-generated.

Interpreting abnormal liver function tests (LFTs) in asymptomatic patients requires a systematic approach. Reviewing LFT patterns, medical history, and physical exams guides further diagnostic testing for liver injury.

Related Experiment Videos

Last Updated: Jun 23, 2026

Laparoscopic S7 Hepatectomy with Positive Fluorescence Staining
07:43

Laparoscopic S7 Hepatectomy with Positive Fluorescence Staining

Published on: May 9, 2025

Area of Science:

  • Hepatology
  • Clinical Biochemistry

Background:

  • Abnormal liver function tests (LFTs) are common in asymptomatic individuals, necessitating efficient diagnostic strategies.
  • The constellation of liver enzymes, bilirubin, and synthetic measures (prothrombin time, albumin) constitute LFTs.
  • A significant percentage of asymptomatic patients present with abnormal LFTs, leading to numerous specialist consultations.

Purpose of the Study:

  • To outline a cost-effective and systematic approach for interpreting abnormal LFTs in asymptomatic patients.
  • To review markers of hepatic injury and diagnostic pathways.
  • To guide clinicians in managing incidental abnormal LFT findings.

Main Methods:

  • Review of patterns of abnormal LFTs.
  • Emphasis on detailed medical history and comprehensive physical examination.
  • Discussion of further investigations including biochemical markers, imaging, and liver biopsy.

Main Results:

  • Abnormal LFTs in asymptomatic patients require a structured diagnostic workup.
  • Identifying patterns of LFT abnormalities is key to initial assessment.
  • Further testing is guided by initial findings and clinical suspicion.

Conclusions:

  • A systematic approach combining LFT pattern review, history, and physical exam is crucial.
  • Targeted biochemical testing and imaging aid in diagnosing the cause of abnormal LFTs.
  • Liver biopsy may be considered in specific cases for definitive diagnosis.